Physician profile
Hailey E Riggs
NPI 1003472242
$2,876.00
in general payments reported to CMS, 2019-2025
37 companies · $1,266 in 2025
The $1,266 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $28.38 · 2023: $384 · 2024: $1,198 · 2025: $1,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,541 · Education: $307.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,540.64 |
| Education | $306.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $465.36 | 2024-2025 | |
| Abbvie INC. | $258.11 | 2023-2025 | |
| Aveo Pharmaceuticals, INC. | $257.63 | 2024-2025 | |
| Janssen Biotech, INC. | $182.24 | 2023-2025 | Erleada, Akeega, Darzalex |
| Astrazeneca Pharmaceuticals LP | $165.99 | 2023-2025 | Tagrisso, Enhertu |
| Genzyme Corporation | $151.02 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $144.29 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $113.65 | 2024-2025 | |
| Seagen INC. | $99.99 | 2025 | |
| Incyte Corporation | $99.35 | 2023-2025 | Jakafi, Monjuvi |
| Regeneron Healthcare Solutions, INC. | $97.09 | 2022-2025 | Libtayo |
| Genmab U.S., INC. | $97.00 | 2023-2025 | Epkinly, Tivdak |
| Takeda Pharmaceuticals U.S.A., INC. | $85.28 | 2024-2025 | Fruzaqla |
| Syndax Pharmaceuticals, INC. | $56.91 | 2025 | |
| Adaptive Biotechnologies Corporation | $51.77 | 2024-2025 | Clonoseq |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hailey Riggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.